The Centers for Medicare & Medicaid Services appears to be quietly considering Palantir to support its yearslong efforts to ...

Cathie Wood's ARK Invest bought $5.56 million of Exact Sciences while selling $8.13 million of Guardant Health on0, 2025.

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of Class A common stock of Palantir Technologies Inc. (NASDAQ: PLTR).

The fund will invest at least 80% of its net assets in derivatives contracts that utilize the Underlying Leveraged ETF as their reference asset. The fund is non-diversified. Low commission rates start ...

Palantir's annual revenue surged from $1.1 billion in 2020 to $2.9 billion in 2024. It also turned profitable in 2023 and more than doubled its net income in 2024. That breakneck growth was driven by ...

Palantir Technologies Inc. (NASDAQ:PLTR) is one of the best big tech stocks to invest in now. On October 16, Palantir ...

Shares of Palantir Technologies (NASDAQ: PLTR) have quadrupled in value during the past year and the company currently has a ...

Federal spending records show Palantir to be one of four recipients to receive awards from the Department of Health and Human ...

Palantir Technologies Inc. (PLTR) closed the most recent trading day at $181.59, moving +1.93% from the previous trading session. The stock outperformed the S&P 500, which registered a daily gain of 1 ...

Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...

Artificial intelligence (AI) has been the primary catalyst fueling Wall Street's rally. AI darlings Nvidia and Palantir ...

Palantir's Q3 earnings are highly anticipated, with guidance for 45%+ YOY revenue growth and sustained high profitability.